Katwijk gives green light to Eli Lilly plant
Council backs permit for multi-billion-euro project expected to create hundreds of jobs.
The municipal council of Katwijk has approved the permit for a new Eli Lilly manufacturing facility. The US pharmaceutical company wants to build a plant near Valkenburg for oral medicines, with an announced investment of approximately €2.6 billion.
The council's decision allows Eli Lilly to continue the permitting procedure. According to public reports, the council also voted against continuing a referendum on the plant's arrival requested by residents.
The plant is to be built in the Zijlhoek-De Woerd area, near Valkenburgse Meer and Leiden Bio Science Park. Eli Lilly wants to produce medicines in pill form there. The site will also include laboratories and offices.
The company announced an investment of $3 billion at the end of 2025. According to its own plans, the site is expected to create approximately 500 direct jobs. An estimated 1,500 additional jobs would be created during construction.
The municipal procedure has been under way since the application was submitted on 3 April. The municipality published studies on, among other things, external safety, traffic, water, nature and the stability of the banks. Residents could submit views; the municipal council gave binding advice as part of the permitting procedure.
The plant's arrival fits the ambition to expand the South Holland life-sciences cluster. For Eli Lilly, the Netherlands is part of a broader European production strategy for oral medicines. According to earlier company plans, the site is intended to strengthen the global supply chain.
The council's decision does not mean that production will begin immediately. First, the formal permit documents and any objection and appeal procedures must be dealt with. The municipality previously indicated that interested parties would have legal options to lodge objections or appeals after the decision was published.
One story, several perspectives
What is established
- The municipal council approved the permit for the planned plant.
- The project involves a multi-billion investment and hundreds of announced direct jobs.
- Residents submitted a referendum request, but the council allowed the project to proceed.
Left
Arguments This perspective emphasises the living environment, democratic participation and the question of whether economic growth outweighs pressure on traffic, nature and safety risks. From this standpoint, large companies must demonstrably provide public added value.
Values Environmental protection, residents' say, the public interest and a fair distribution of benefits and burdens.
Consequences A plant can create jobs, but it can also place lasting pressure on space and infrastructure. Without strong conditions, the community may bear the risks while the profits go elsewhere.
Centre
Arguments The institutional approach sees the permit as a balancing exercise in which economic development, spatial planning and safety must be assessed together. The decision must be open to scrutiny and subject to objection and appeal.
Values Careful procedures, proportionality, regional cooperation and predictable business-location policy.
Consequences The project could strengthen the life-sciences cluster, provided agreements on traffic, housing, water and safety are observed and periodically evaluated.
Right
Arguments This perspective emphasises foreign investment, strategic medicines production and the need for municipalities to make room for companies that provide jobs and tax revenue. Lengthy procedures can send investments to other countries.
Values Economic growth, entrepreneurship, international competitiveness and decisive governance.
Consequences Rapid implementation could strengthen the region economically and support the security of medicines supplies. Excessively onerous local conditions could make the project more expensive or less attractive.
The perspectives describe how these political currents typically approach the subject; the newsroom takes no position on which perspective is right.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The approval, location, investment and employment estimates have been confirmed by multiple public sources. The text makes clear that construction and production have not yet begun.
- confirmed The municipal council of Katwijk approved the permit for Eli Lilly. — Reported by NL Times; the municipality's procedure page confirms the decision-making. source
- confirmed The investment amounts to approximately €2.6 billion or $3 billion. — The Dutch government letter cites €2.6 billion; Lilly announced $3 billion. source
- confirmed The site is expected to create approximately 500 direct jobs. — Mentioned in Lilly's announcement and the letter to the Lower House (Tweede Kamer). source
- confirmed The council voted against continuing a referendum request. — The outcome was reported by NL Times; the municipality described the possible decision routes beforehand. source
Editor's note
The council decision and the scale of the project were confirmed by public reporting and company and municipal information. At the time of writing, the formal publication of all final permit documents had not yet been located.Sources
- Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant — NL Times
- Nieuwe vestiging geneesmiddelenbedrijf Lilly in Katwijk — Gemeente Katwijk
- Raad ontvangt verzoek voor referendum over ontwerpbesluit Eli Lilly — Gemeente Katwijk
- Lilly plans to build a new $3 billion facility — Eli Lilly and Company
- Indiening vergunningsaanvraag productiefaciliteit — Eli Lilly Nederland